Patent Assignment
Reel/Frame 057289/0972
Assignment of Assignor's Interest
Recorded: 2021-08-25
Pages: 3
Assignor
OROZCO, JOHNNIE J.
Executed: 2021-01-22
Assignee
FRED HUTCHINSON CANCER RESEARCH CENTER
1100 FAIRVIEW AVENUE NORTH, SEATTLE, WASHINGTON, 98109
Covered Property
(1)
Bispecific Affinity Reagent and Related Methods for Pretargeted Radioimmunotherapy Against CD45+ Cells
Application:
17/260,205 →
Publication:
US 2021/0269526
Related Assignments
(2)
Other recorded transfers of the patent in this record — the chain of ownership.
Merger and Change of Name
Jun 8, 2022
From: FRED HUTCHINSON CANCER RESEARCH CENTER; SEATTLE CANCER CARE ALLIANCE
To: FRED HUTCHINSON CANCER CENTER
Reel/Frame 060838/0852 →
Confirmatory License
Oct 12, 2022
From: FRED HUTCHINSON CANCER RESEARCH CENTER
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 061661/0035 →